In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii

Journal of Antibiotics

Volumn 63, Issue 2, 2010, Pages 51-53

  Dizbay, Murat ^a   Tozlu, Derya Keten ^a   Cirak, Meltem Yalinay ^a   Isik, Yasemin ^a   Ozdemir, Kevser ^a   Arman, Dilek ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Colistin; Combination; Rifampin; Synergy; Tigecycline

Indexed keywords

COLISTIN; RIFAMPICIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENTIATION; EPSILOMETER TEST; NONHUMAN; PRIORITY JOURNAL; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

ACINETOBACTER BAUMANNII;

EID: 77950193786     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.117     Document Type: Article

References (24)

1. Perez, F. et al. Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents. Chemother. 51, 3471-3784 (2007).
2. +19045. Available online: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19045 (2008).
3. Vila, J. & Pachón, J. Therapeutic options for Acinetobacter baumannii infections. Expert. Opin. Pharmacother. 9, 587-599 (2008).
4. Dizbay, M., Caglar, O. & Arman, D. In vitro synergistic effect of cefoperazone-sulbactam and netilmicin combination in multidrug resistant Acinetobacter baumannii strains isolated from ventilator associated pneumonia. J. ANKEM. 22, 28-31 (2008).
5. Lee, C. M., Lim, H. K., Liu, C. P. & Tseng, H. K. Treatment of pan-drug resistant Acinetobacter baumannii. Scand. J. Infect. Dis. 37, 195-199 (2005).
6. Pachon-Ibanez, M. E., Jimenez-Mejias, M. E., Pichardo, C., Llanos, A. C. & Pachon, J. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob. Agents. Chemother. 48, 4479-4481 (2004).
7. Souli,M.et al. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, Gram-negative and Gram-positive clinical isolates from Greek hospitals. Antimicrob. Agents. Chemother. 50, 3166-3169 (2006).
8. Dizbay, M., Altuncekic, A., Ergut Sezer, B., Ozdemir, K. & Arman, D. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int. J. Antimicrob. Agents. 32, 29-32 (2008).
9. Gales, A. C., Reis, A. O. & Jones, R. N. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39, 183-190 (2001).
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement, CLSI document M100-S17 (CLSI, Wayne, Pennsylvania, 2007).
11. Prashanth, K. & Badrinath, S. Epidemiological investigation of nosocomial Acinetobacter infections using arbitrarily primed PCR & pulse field gel electrophoresis. Indian J. Med. Res. 122, 408-418 (2005).
12. Ranjbar, R. et al. Antimicrobial susceptibility and AP-PCR typing of Acinetobacter spp. strains. Iranian J. Publ. Health. 36, 50-56 (2007).
13. Korten, V., Ulusoy, S., Zarakolu, P., Mete, B. & Turkish MYSTIC Study Group Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program. Diagn. Microbiol. Infect. Dis. 59, 453-457 (2007).
14. Hsueh, P. R. et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan. Emerg. Infect. Dis. 8, 827-832 (2002).
15. Fritsche, T. R., Sader, H. S., Stilwell, M. G., Dowzicky, M. J. & Jones, R. N. Antimicrobial activity of tigecycline tested against organisms causing communityacquired respiratory tract infection and nosocomial pneumonia. Diagn. Microbiol. Infect. Dis. 52, 187-193 (2005).
16. Sader, H. S., Jones, R. N., Dowzicky, M. J. & Fritsche, T. R. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn. Microbiol. Infect. Dis. 52, 203-208 (2005).
17. Timurkaynak, F. et al. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Int. J. Antimicrob. Agents. 27, 224-228 (2006).
18. Linden, P. K. & Paterson, D. L. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin. Infect. Dis. 43(Suppl 2), S89-94 (2006).
19. Kallel, H. et al. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Int. J. Antimicrob. Agents. 28, 366-369 (2006).
20. Giamarellou, H., Antoniadou, A. & Kanellakopoulou, K. Acinetobacter baumannii: a universal threat to public health? Int. J. Antimicrob. Agents. 32, 106-119 (2008).
21. Lolans, K., Rice, T. W., Munoz-Price, S. & Quinn, J. P. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents. Chemother. 50, 2941-2945 (2006).
22. Navon-Venezia, S., Leavitt, A. & Carmeli, Y. High tigecycline resistance in multidrug- resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 59, 772-774 (2007).
23. Peleg, A. Y. et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J. Antimicrob. Chemother. 59, 128-131 (2007).
24. Saballs, M. et al. Rifampicin/imipenem combination in the treatment of carbapenemresistant Acinetobacter baumannii infections. J. Antimicrob. Chemother. 58, 697-700 (2006).